Candice D. Johnson is an associate in the Denver office of Gibson Dunn where she practices in the firm’s Capital Markets practice group, focusing on representing leading life sciences companies and investors. Candice advises clients on a wide range of financing transactions and compliance matters, including initial public offerings, follow-on and secondary equity offerings, at-the-market offerings, and private placements, as well as reverse merger transactions, corporate law matters, Securities and Exchange Commission reporting requirements and ownership filings, and corporate governance matters.
Selected Transactions
- Initial Public Offerings: Apogee Therapeutics, Zevia PBC, Viant Technology, Shattuck Labs, 89bio, StepStone Group
- Follow-on Equity Offerings: Cogent Biosciences, Apogee Therapeutics, Gyre Therapeutics, 89bio, Assertio Holdings, Excelerate Energy, X4 Therapeutics, Odonate Therapeutics, Biora Therapeutics
- PIPE Offerings: Jade Biosciences, Shattuck Labs, Biora Therapeutics
- ATM Facilities: Apogee Therapeutics, Biora Therapeutics, Cogent Biosciences, CTI BioPharma, 89bio, Gyre Therapeutics, Newegg Commerce, Shattuck Labs, X4 Therapeutics, Zevia PBC
- Debt Offerings: Cogent Biosciences, Jade Biosciences, Biora Therapeutics, Wells Fargo & Company and Wells Fargo Bank, N.A., Huntington National Bank, Par Technology, Keysight Technologies, Magnite, Verisign
- Mergers and Acquisitions:
- Jade Biosciences in its business combination with Aerovate Therapeutics
- Neurogene in its business combination with Neoleukin Therapeutics
- Gyre Therapeutics in its business combination with Catalyst Biosciences
- SomaLogic in its acquisition of Palamedrix
Candice earned her Juris Doctor from the University of Virginia School of Law in 2018. During law school, she served as a member of the editorial board for the Journal of Law and Politics and was twice selected to be part of the competitive Peer Advisor program. She also served as President of the Law Christian Fellowship. Candice earned her Bachelor of Arts degree, summa cum laude, with a double major in History and Philosophy, Politics, Economics, & Law and a minor in English from the University of Arizona in 2014. She graduated with honors and was elected to Phi Beta Kappa.
Candice is admitted to practice law in the state of Colorado.
Capabilities
Credentials
Education:
- University of Virginia - 2018 Juris Doctor
- University of Arizona - 2014 Bachelor of Arts
Admissions:
- Colorado Bar
News & Insights
Firm News
Gibson Dunn Advising Yarrow Bioscience on Merger with VYNE Therapeutics and Concurrent $200 Million Financings
Firm News
Gibson Dunn Represented Cogent Biosciences in Concurrent Public Offerings of Common Stock and Convertible Notes with Aggregate Gross Proceeds of $575 Million
Firm News
Gibson Dunn Advised X4 Pharmaceuticals on Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares